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Abstract 
Objective: This study was conducted to investigate the involvement of oxidative damage in rat model 
of osteoarthritis treated with Mesenchymal Stem Cell Wharton Jelly (MSC-WJ) and to elucidate 
whether oxidative stress indicators correlate with cartilage damage and catalase activity.  Methods: 
This research is an experimental research with Posttest-Only Control Group Design. The sample 
consisted of 30 OA rat divided into 5 groups: group I was the OA rat control group, group II was the OA 
rat group after 4 weeks, group III was the OA rat group after 8 weeks, group IV was the OA rat group 
after 4 weeks of treatment with MSC-WJ and group V is the OA rat group after 8 weeks treated with 
MSC-WJ. Malondialdehyde (MDA) were measured by Ohkawa method, Cartilage Thickness were 
measured by using the Betaview program, as well as the 3.1MP Beta camera Sony exmor CMOS Sensor 
and catalse (CAT) activity were measured by modification of Shinha.  Results: The results showed that 
the analysis of the Correlation between MDA with Cartilage Thickness (r = – 0.665) and CAT activity (r 
= – 0.666) in osteoarthritis Model Rat after Mesenchymal Stem Cell Wharton’s Jelly Treatment. 
Conclusion: This study demonstrated a strong negative correlation between oxidative stress and knee 
cartilage thickness and catalase activity of MSC-WJ treated OA rats.  
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Osteoarthritis (OA) is a complex disorder 
that affects many different joints, being a 
major cause of disability in the general 
population. It is characterized by 
morphological, biochemical, molecular and 
biomechanical changes of the cells and the 
extracellular matrix (ECM) that cause 
softening, fibrillation, ulceration, loss of 
articular cartilage, synovial inflammation, 
subchondral bone sclerosis, osteophyte 
formation and subchondral cysts. OA is a 
multifactorial and polygenic disease and its 
pathogenesis is influenced by several 
genetic and environmental factors 
associated with the activation of molecular 
pathways that contribute to the 
development of articular injuries.1  
Swelling of the joints is one of the clinical 
features of OA that is associated with 
inflammation and reflect their synovitis 
due to thickening of the synovium or 
effusion.2  Inflammation is triggered by 
external mediators such as cytokines and 
proteases, and internal cellular 
mechanisms that lead to increased 
production of inflammatory mediators and 
the lack of elimination of oxidized proteins. 
This protein in turn increases the 
concentration of reactive oxygen species 
(ROS) in cells, which further increases the 
oxidative damage that triggers 
inflammation.3  Oxidative stress can 
promote cellular aging, and in particular 
chondrocyte aging.4 Oxidative stress can 
also cause cell apoptosis and release of 
cellular content into the extracellular 
environment. Overall, degradation 
products and cellular content containing 
oxidized molecules can form a vicious 
circle, which is formed by newly formed 
ROS and further degradation products.5 
Synovial inflammation plays an important 
role in the pathogenesis of OA and 
oxidative stress is present in the OA 
cartilage membrane. Under basal 
conditions, synovial cells express both 
iNOS and NADPH oxidase.6 Inflammatory 
reactions in the synovium are controlled by 
several biochemical factors, including 
prostanoids, cytokines (IL-1α, IL-1β, TNF-α, 
PGE2), proteases and ROS produced by 
synoviocytes and chondrocytes. ROS 
contribute to inflammation-associated 
tissue degradation.7 
Joint cartilage secretes various 
antioxidants as a cellular defense against 
the harmful effects of ROS. ROS are free 
radicals that contain oxygen molecules 
such as hydroxyl radical (•OH), hydrogen 
peroxide (H2O2), superoxide anion (O2•−), 
nitric oxide (NO) and hypochlorite anion 
(OCl-).8 An understanding of the molecular 
pathways and their interactions with 
different joint  tissues needs to develop 
new approaches for the prevention and 
treatment of OA. Recent studies have 
concluded that the development of OA is 
significantly associated with oxidative 
stress and reactive oxygen species 
(ROS).9,10  
ROS are produced at low levels in articular 
chondrocytes, mainly by NADPH oxidase, 
and they act as integral actors of 
intracellular signaling mechanisms that 
contribute to the maintenance of cartilage 
homeostasis as they modulate 
chondrocyte apoptosis, gene expression, 
ECM synthesis and degradation as well as 
cytokine production.11-14  ROS production 
and oxidative stress were found to be 
increased in patients with OA.15-17 OA 
cartilage has significantly more ROS-
induced DNA damage than normal 
cartilage and this damage is mediated by 










implication of ROS in cartilage degradation 
comes from the presence of lipid 
peroxidation products.14.19-22 In contrast, 
antioxidant enzymes, such as superoxide 
dismutase (SOD), CAT, GPX and PON1 were 
decreased in OA patients. This confirms the 
role of oxidative stress in the pathogenesis 
of OA.16,17,23-27 
Lipid peroxidation derived from 
chondrocytes is a major source of oxidative 
stress where ROS can cause cartilage 
collagen degradation, structural 
destabilization of the ECM, and cartilage 
aging through attack of polyunsaturated 
fatty acids on membrane lipids.28-30 Lipid 
peroxidation produces various 
hydroperoxide and aldehyde products, 
such as malondialdehyde (MDA) and 4-
hydroxynonenal (HNE) which are highly 
reactive to cellular components and ECM. 
Excessive binding of these reactive 
aldehydes to ECM and cellular proteins can 
alter cellular function, membrane 
permeability, electrolyte balance, thereby 
causing matrix protein degradation.31 
Elevated levels of MDA and HNE have been 
reported in plasma and synovial fluid of OA 
patients and these are the most commonly 
applied parameters for lipid peroxidation 
indicators. 29,32-34 MDA mediates the 
oxidation of cartilage collagen while HNE 
causes ROS emission that activates the 
MAPK pathway.35 
Hydrogen peroxide (H2O2) induces 
chondrocyte cell death in a dose-
dependent manner.36 H2O2 produced by 
the hypoxanthine-xanthine oxidase (XOD) 
system causes inhibition of articular 
chondrocyte growth.37 H2O2 produced in 
excess amounts can be a mediator of 
cellular damage. Excessive hydrogen 
peroxide production can occur both 
exogenously and endogenously. 
Exogenously, hydrogen peroxide can be 
formed during the acute inflammatory 
phase of osteoarthritis and rheumatoid 
arthritis involving neutrophils and 
macrophages. Endogenously, the 
production of hydrogen peroxide by 
chondrocytes occurs via NADPH oxidase. 
Excessive exposure to hydrogen peroxide 
on chondrocytes can cause various effects, 
namely cell apoptosis, production of lipid 
peroxidation, inhibition of synthesis and 
degradation of proteoglycans.38 Catalase is 
an antioxidant that plays an important role 
in neutralizing hydrogen peroxide. 
This study aims to determine the 
correlation of MDA with cartilage thickness 
and catalase in OA rats after treatment 




Animals and Experimental Design 
Male white rats (Rattus novergicus) 
weighing between 250 - 300 grams. The 
experimental animals were placed in clean 
cages, disinfected and free of pathogens 
and given standard food in the form of 
pellets and drinking ad libitum. The 
experimental animals were adapted for 1 
week before treatment. 
 
Osteoarthritis Induction 
Osteoarthritis was induced by single 
injection of intraarticular iodoacetate into 
the knee joints of anesthetized mice by 
means of intraperitoneal injection of 0.1 ml 
10% xylazine and 0.2 ml 10% ketamine.39-41  
Prepare an monosodium iodoacetate 
(MIA) solution with a concentration of 20 
mg / ml (sterile 0.9% NaCl solvent). After 
anesthetizing the rat's left leg was bent 90° 
at the knee. The patellar ligament is felt 
under the kneecap and is injected into this 
area. Each mouse received 0.05 mL 










using a gas tight glass syringe with 27 0.5-
inch needle sizes.39,42  Twenty four rats 
(three weeks after induction of MIA, Janusz 
et al. (2001) were divided into 4 groups. 
The OA rat group after 4 weeks, the OA rat 
group after 8 weeks, the OA rat group was 
treated with MSC-WJ for 4 weeks and the 
OA rat group was treated with MSC-WJ for 
8 weeks. The treated group of OA rat was 
given 50 L of MSC-WJ at a dose of 1 x 106 
cells to the left knee, the control group and 
the untreated group were given complete 
medium after anesthesia. 
 
Blood Collection and Knee Joints 
Blood and Knee Joints were collected from 
the healthy rat group, the OA rat group 
after 4 weeks, the OA rat group after 8 
weeks, the OA rat group was treated with 
MSC-WJ for 4 weeks and the OA rat group 
was treated with MSC-WJ for 8 weeks.  
 
Histological Analysis 
The rat knee joint was fixed with 10% 
formalin buffered phosphate, then 
decalcified in 8% HCl for 1 week. 
Furthermore, it is processed into paraffin 
blocks and cut with a microtome with a 
thickness of 4 µm. The results of the 
cutting in the form of a ribbon are placed 
on the surface of warm water at a 
temperature of 450C with the aim of 
eliminating folds in the ribbon due to 
cutting. Each ribbon (strip) was stained 
with Haematoxilin and Eosin.  
The thickness of the cartilage is assessed 
using the Betaview program, as well as the 
Beta 3.1MP Sony exmor CMOS Sensor at 
100 x microscopic magnification by 
measuring the thickness of cartilage from 
the joint surface to the bone and cartilage 
boundaries perpendicularly. 
Measurements were carried out at 10 
different points with a distance of 
approximately 200µm from each 
measurement point. 
Flow cytometry Analysis 
Mesenchymal stem cells used for the test 
were passage 3. MSC-WJ passage 1 
originated from the human umbilical cord 
(UC-MSC) obtained from the UPT of Stem 
Cell Medicine Technology RSCM FKUI. 
Based on flow cytometry analysis, this 
MSC-WJ has expression of CD73-APC cell 
surface markers 99.8%, CD105-PerCP-
Cys5.5 95% and CD90-FITC 99.9%. Then 
MSC-WJ passage 1 is silenced (developed) 
and MSC passage 3 is obtained. 
 
 
Figure 1: Data on Characteristics of 
Mesenchymal Stem Cells Wharton Jelly. (A) 
Cells MSC-WJ reach confluence. Scale bar: 
500 μM. Photographs of cells taken using a 
Nikon Ti-S microscope; (B) Data flow 
cytometry. Forward scatter (FCS) plot & 
side scatter (SSC) plot. Population gated 
events (P1): 20,000; (C) Cell surface 
markers expression: CD73-APC 99.8% and 
CD105-PerCP-Cy5.5 95%; (D) Cell surface 
markers expression: CD90-FITC 99.9% and 
Lin (-) -PE 0.4% 
 
Determination of MDA concentration 
MDA concentration was measured 
fluorometrically as 2-thiobarbituric acid-










Ohkawa method. SF sample was mixed 
with 8.1% sodium dodecyl sulfate, 20% 
acetic acid and 0.8% 2-thiobarbituric acid. 
The method was modified by adding 
sodiumsulphate (100 mmol/l) and 3,5-
diisobutylo-4-hydroxytoluen(2.5mmol/l). 
After vortexing, SF sample was incubated 
for 1 h in 950C and butanole - pyridine 15:1 
(v/v) was added. The mixture was shaken 
10 min and then centrifuged. Butanole - 
pyridine layer was measured 
fluorometrically at 552 nm (515 nm 
excitation). TBARS value is expressed as 
malonyldialdehyde equivalent. Tetra 
ethoxypropane was used as the standard. 
Data are shown as micromole MDA/l SF 
(mmol/l).43 
 
Assay of Catalase Activity 
This was carried out using the method 
described by Sinha method. 0.2 ml of 
sample (serum, and liver, heart, and kidney 
homogenates’ supernatant) was mixed 
with 0.8 ml distilled H2O to give 1 in 5 
dilution of the sample. The assay mixture 
contained 2 ml of solution (800 μmol) and 
2.5 ml of phosphate buffer in a 10 ml flat 
bottom flask. Properly diluted enzyme 
preparation (0.5 ml) was rapidly mixed 
with the reaction mixture by a gentle 
swirling motion. The reaction was run at 
room temperature. A 1 ml portion of the 
reaction mixture was withdrawn and 
blown into 1 ml dichromate/acetic acid 
reagent at 60 seconds intervals. The 
hydrogen peroxide content of the 
withdrawn sample was determined.44 
 
Research Ethics 
This research has received ethical 
consideration and approval from the 
Research Ethics Committee Team of the 
Faculty of Medicine, Andalas University 
with registration number 349/ 
KEP/FK/2019. 
Statistical Analysis 
The data are expressed as means ± 
standard deviations and testing of 
correlations by use of Pearson’s test. The p 
value <0.05 was said to be statistically 
significant. 
 
RESULT AND DISCUSSION 
Study of 24 male osteoarthritis rats 
induced by monosodium iodoacetate 
(MIA) for 3 weeks. The OA rats were 
divided into 4 groups, two groups of 
untreated OA rats  (OA rats 4 weeks and 8 
weeks) and the other 2 groups treated with 
MSC-WJ for 4 weeks and 8 weeks. 
 
Histophatology 
The results of the histopathological 
examination of the knee joint tissue 
showed changes in cartilage thickness 
(Figure 2).  
 
Figure 2. Comparison of histology of genu 
joint tissue between experimental and 
treatment groups. Healthy (a, f), 
osteoarthritis 4 weeks (b, g), osteoarthritis 
8 weeks (c, h), osteoarthritis MSC-WJ 
treatment 4 weeks (d, i) and osteoarthritis 
treated by MSC-WJ 8 weeks (e, j). The joint 
tissue of osteoarthritis animals showed a 
decrease in joint cartilage thickness with a 
thin cartilage area (arrow). On MSC-WJ 
administration, there was an increase in 
joint cartilage thickness compared to 
positive controls (OA 4 weeks and OA 8 













Biomarker Stres oksidatif 
 
Table 1. MDA levels, knee cartilage 
thickness and catalase activity 
 
Variable 



















































As can be seen in Table 1, MDA 
concentrations increased, whereas 
cartilage thickness and catalase activity 
decreased after MIA induced (4 and 8 
weeks) compared to healthy rats. 
As can be seen in Table 1, MDA 
concentrations increased, whereas 
cartilage thickness and catalase activity 
decreased after MIA induced (4 and 8 
weeks) compared to healthy rats. 
However, there was a decrease in MDA 
levels, an increase in cartilage thickness 
and catalase activity after treatment with 
MSC-WJ (4 and 8 weeks). 
 
Table 2. Correlation test result between 
MDA with Joint cartilage thickness and 
Catalase 
Variable  Joint cartilage 
thickness 

















- 0.665 0.0001  
30 
- 0.666 0.0001 
The results showed a strong relationship 
between MDA as an indicator of lipid 
peroxidation with knee cartilage thickness 
(r = - 0.665) and catalase activity (r = - 
0.666) which had a negative pattern. There 
was a significant relationship between 
MDA with knee cartilage thickness 
(p=0.0001) and catalase activity (p=0.0001) 
(Table 2). MDA contributed 44.2% to the 
thickness of knee cartilage (R2 Linear = -
0.442) and contributed 44.4% to serum 
catalase activity  (R2 Linear = -0.444) 
(Figure 3). 
    
         a       b 
Figure 3. Significant correlation between 
MDA levels with cartilage thickness (a) and 
catalase activity (b) was found both in vivo 
studies.  
 
Relationship between MDA and knee 
cartilage thickness  
The results showed a negative relationship 
between serum MDA levels and knee 
cartilage thickness, where decreasing MDA 
levels in MSC-WJ-treated rat serum caused 
an increase in knee cartilage thickness 
(Figure 2 and table 2). 
MDA is an indicator of the occurrence of 
lipid peroxidation carried out by reactive 
oxygen species (ROS). Where the 
production of ROS is increased in cases of 
OA.15-17 Evidence for the implication of ROS 
in cartilage degradation comes from the 
presence of lipid peroxidation  
products,14,19,45 which is seen by the 
increased production of MDA in animal 
models of OA.46 The binding of MDA to the 
ECM and cellular proteins will cause matrix 
degradation.31 Osteoarthritis sufferers 
experience an increase in MDA in their 
synovial fluid and blood plasma.47 Grigolo 
et al. (2003) found that chondrocytes from 










vitro generate ROS and significantly 
accelerate lipid peroxidation.48 According 
to Hiran et al. (1997) that articular 
chondrocytes can release ROS using 
nicotinamide adeninedinucleotide 
phosphate (NADPH) oxidase.49 NADPH 
oxidase expressed by chondrocytes is the 
main enzyme responsible for ROS 
generation in synovial fluid, which 
contributes to increased oxidative stress 
within joints and mediates the progressive 
cartilage degradation that accompanies 
OA.50,51 
Exposure of articular chondrocytes to H2O2 
inhibits proteoglycan synthesis,52,53 
apoptotic cell death,54 lipid peroxidation28 
and proteoglycan (PG) degradation.55 The 
ineffectiveness of scavengers against 
hydroxyl radicals in disease models 
suggests that H2O2 itself is a major 
mediator of cartilage degeneration.36 
ROS can cause damage to all components 
of the ECM. Free radicals attack directly on 
proteoglycan and collagen molecules and 
prevent the formation of collagen 
fibrils.37,56,57 In the presence of oxygen, 
•OH degrades collagen and changes its 
amino acid composition. Incubation of 
acid-soluble type I collagen with the 
superoxide radical anion, which is 
generated by the XOD system, degrades 
collagen and prevents the formation of 
collagen fibrils.58 Most in vitro studies 
indicate that ROS play a role in cartilage 
degradation, as reflected by their effect on 
matrix components and chondrocyte 
properties.14 
This study showed that treatment with 
MSC-WJ could increase cartilage thickness 
in animal models that experienced 
thinning during OA propagation. The 
results of our previous study also showed 
the occurrence of cartilage repair in OA 
model rat treated with MSC-WJ,59 because 
MSCs can differentiate into chondrocytes 
that play a role in producing cartilage 
matrix.60 
MSCs are multipotent stem cells that have 
the ability to self-review and intrinsically 
repair and regenerate the tissues in which 
they reside after damage or trauma. MSCs 
have the capacity to differentiate into 
various other connective tissues such as 
cartilage, bone, tendon, adipose tissue. 61 
 
Relationship between MDA and Catalase  
The results showed a negative relationship 
between serum MDA levels and catalase, 
where decreasing MDA levels in the serum 
of MSC-WJ-treated rats led to increased 
catalase activity (Figure 2 and Table 2). 
Disruption of the joint components 
through knee injury can lead to increased 
production of O2•−, in part due to the 
release and oxidation of hemoglobin from 
erythrocytes by activation of NADPH 
oxidase.62,63 O2•− formed can be converted 
into H2O2 or •OH. In vivo hydrogen 
peroxide is detoxified and metabolized by 
the antioxidant enzymes CAT and 
glutathione peroxidase (GPX).46 H2O2 
produced by the hypoxanthine-xanthine 
oxidase (XOD) system causes inhibition of 
articular chondrocyte growth.37 
Under normal circumstances, ROS are 
eliminated by scavenging and 
detoxification reactions, which are 
catalyzed mainly by antioxidant enzymes: 
SOD, CAT and glutathione transforming 
enzymes, including GPX, glutathione 
reductase (GR) and glutathione-S-
transferase (GST). The first line of defense 
against ROS is SOD, which removes O2- by 
catalyzing a dismutation reaction. CAT 
protects cells and tissues by directly 










absence or dysfunction of some of these 
defense systems makes cells and tissues 
susceptible to oxidative damage.24 Ivanova 
and Ivanova (2000) found that there was 
no SOD and low levels of CAT in the 
synovial fluid (SF) of osteoarthritic joints.65 
It has been demonstrated that MSCs are 
resistant to oxidative stimuli in vitro 
associated with antioxidant enzymes 
which are constitutively expressed as 
SOD1, SOD2, CAT and GPx.66 In addition to 
using constitutive antioxidants, MSCs are 
also capable of significant adaptations in 
response to redox stress.67 
Treatment with MSCs showed a decrease 
in ROS levels 68.69 because MSCs have been 
shown to reduce H2O2 and O2.- levels in 
cases of inflammatory diseases.70,71,72 So 
that the use of catalase will be reduced to 
decompose H2O2. In addition, MSCs also 
constitutively express antioxidant enzymes 
such as SOD1, SOD2, CAT, and GPx.67 So 
that catalase activity can be increased in 
animal models of OA treated with MSC-WJ. 
Therefore, both CAT and GPx may play a 
role in MSC therapy in reducing oxidative 
stress by removing H2O2 which acts as an 
inducer of cell death in vitro.73  
 
CONCLUSION 
Based on the results of the research that has 
been done, it can be concluded that there is 
a strong correlation between MDA serum 
dan ketebalan tulang rawan dan aktivitas 
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